ReviewExploration of targeted anti-tumor therapy2022

Antibody-drug conjugate therapies in multiple myeloma-what's next on the horizon?

Monique Hartley-Brown et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.